Table 2 Characteristics of the patient population switching from Escitalopram to another AD.
Total [N, %] | Switched to TCA, [N, %] | Switched to SSRI, [N, %] | Switched to other AD, [N, %] | |||||
|---|---|---|---|---|---|---|---|---|
2 638 | 263, 10.0 | 420, 15.9 | 1 955, 74.1 | |||||
nPGx | PGx | nPGx | PGx | nPGx | PGx | nPGx | PGx | |
Total | 1 705, 64.6 | 933, 35.4 | 0, 0.0 | 263, 28.2 | 93, 5.5 | 327, 35.0 | 1 612, 94.5 | 343, 36.8 |
Gender | ||||||||
Male | 647, 37.9 | 306, 32.8 | 0, 0.0 | 79, 30.0 | 24, 25.8 | 103, 31.5 | 623, 38.6 | 124, 36.2 |
Female | 1 058, 62.1 | 627, 67.2 | 0, 0.0 | 184, 70 | 69, 74.2 | 224, 68.5 | 989, 61.4 | 219, 63.8 |
age group (in years) | ||||||||
0–19 | 34, 2.0 | 30, 3.2 | 0, 0.0 | 10, 3.8 | 3, 3.2 | 13, 4.0 | 31, 1.9 | 7, 2.1 |
20–39 | 399, 23.4 | 253, 27.1 | 0, 0.0 | 40, 15.2 | 36, 38.7 | 93, 28.5 | 363, 22.5 | 12, 35.0 |
40–64 | 652, 38.2 | 381, 40.8 | 0, 0.0 | 115, 43.7 | 45, 48.4 | 126, 38.5 | 606, 37.6 | 140, 40.8 |
65–79 | 309, 18.1 | 163, 17.5 | 0, 0.0 | 66, 25.1 | 5, 5.4 | 53, 16.2 | 304, 18.9 | 44, 12.8 |
80+ | 311, 18.3 | 106, 11.4 | 0, 0.0 | 32, 12.2 | 4, 4.3 | 42, 12.8 | 307, 19.1 | 32, 9.3 |
Region | ||||||||
Zurich | 360, 21.1 | 203, 21.8 | 0, 0.0 | 60, 22.8 | 14, 18.3 | 73, 22.3 | 343, 21.3 | 70, 20.4 |
Espace Mittelland | 393, 23.0 | 205, 21.9 | 0, 0.0 | 60, 22.8 | 19, 20.5 | 74, 22.6 | 373, 23.2 | 71, 20.7 |
Lemanic Region | 254, 14.9 | 180, 19.3 | 0, 0.0 | 20, 7.6 | 32, 34.4 | 78, 23.9 | 222, 13.8 | 82, 23.9 |
Northwestern Switzerland | 278, 16.3 | 126, 13.5 | 0, 0.0 | 42, 16.0 | 3, 3.2 | 34, 10.4 | 274, 17.0 | 50, 14.6 |
Eastern Switzerland | 182, 10.7 | 97, 10.4 | 0, 0.0 | 44, 16.7 | 4, 4.3 | 24, 7.3 | 178, 11.1 | 29, 8.5 |
Ticino | 122, 7.2 | 66, 7.1 | 0, 0.0 | 12, 4.6 | 10, 10.7 | 32, 9.8 | 112, 6.9 | 22, 6.4 |
Central Switzerland | 105, 6.2 | 53, 5.7 | 0, 0.0 | 25, 9.5 | 7, 7.5 | 11, 3.4 | 98, 6.1 | 17, 4.9 |
No information about region | 11, 0.6 | 3, 0.3 | 0, 0.0 | 0, 0.0 | 1, 1.1 | 1, 0.3 | 10, 0.6 | 2, 0.6 |
